Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy

Trinh, Quoc-Dien; Sukumar, Shyam; Schmitges, Jan; Bianchi, Marco; Sun, Maxine; Shariat, Shahrokh; Sammon, Jesse; Jeldres, Claudio; Zorn, Kevin; Perrotte, Paul; Graefen, Markus; Rogers, Craig; Peabody, James; Menon, Mani; Karakiewicz, Pierre
June 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jun2013, Vol. 20 Issue 6, p2096
Academic Journal
No abstract available.


Related Articles

  • The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma. Capitanio, Umberto; Matloob, Rayan; Suardi, Nazareno; Abdollah, Firas; Castiglione, Fabio; Di Trapani, Dario; Russo, Andrea; Briganti, Alberto; Carenzi, Cristina; Salonia, Andrea; Montorsi, Francesco; Rigatti, Patrizio; Bertini, Roberto // Urologia;2012, Vol. 79 Issue 2, p109 

    BACKGROUND: Controversies exist regarding the effect of lymphadenectomy (LND) in renal cell carcinoma (RCC). We hypothesized that patients with locally advanced cancer invading beyond Gerota's fascia (pT4 Nany Many RCC) might benefit from an extended LND not only for staging but also for...

  • Secondary Debulking Including Nephrectomy in Recurrent Uterine Carcinosarcoma: A Case Report. Kushnir, Christina L.; Fleury, Aimee C.; Futoran, Robert J.; Spirtos, Nick M. // Clinical Ovarian Cancer;May2010, Vol. 3 Issue 1, p59 

    The role of secondary cytoreduction in the treatment of recurrent uterine carcinosarcoma is controversial. This report explores the effectiveness of secondary debulking for an isolated recurrence. We report the case of a 59-year-old patient with recurrent uterine carcinosarcoma who underwent...

  • Multiple metastases of renal clear cell carcinoma to the organs of the head. Sawicki, Piotr; Kaźmierczak, Wojciech; Burduk, Paweł; Kaźmierczak, Henryk // Contemporary Oncology / Wspolczesna Onkologia;2014, Vol. 18 Issue 6, p448 

    Metastases of renal clear cell carcinoma to the organs of the head are rare. Single cases show that they can appear either shortly after or many years after radical surgery. The diagnosis of this cancer is difficult because of its insidious course; therefore, it is often diagnosed too late. Late...

  • Adjuvant IL-2 offers survival benefit in metastatic RCC. Bowser, Andrew // Urology Times;Sep2002, Vol. 30 Issue 9, p4 

    Reports on the chance of survival of patients with metastatic renal cell carcinoma using adjuvant interleukin-2 after cytoreductive nephrectomy. Response of patients; 5-year survival rate of patients in the IL-2 group; Attitude of physicians to nephrectomy.

  • The impact of type 2 diabetes on the outcome of localized renal cell carcinoma. Höfner, Thomas; Zeier, Martin; Hatiboglu, Gencay; Eisen, Christian; Schönberg, Gita; Hadaschik, Boris; Teber, Dogu; Duensing, Stefan; Trumpp, Andreas; Hohenfellner, Markus; Pahernik, Sascha // World Journal of Urology;Dec2014, Vol. 32 Issue 6, p1537 

    Purpose: To evaluate the influence of type 2 diabetes on cancer-specific outcome in patients undergoing surgery for localized renal cell carcinoma (RCC). Methods: A total of 1,140 patients with localized RCC undergoing radical or partial nephrectomy were enrolled into this retrospective...

  • Неоадъювантная таргетная терапия у боль... Алексеев, Б. Я.; Нюшко, К. М.; Калпинский, А. С. // Ophthalmology (1816-5095);jun2015, Vol. 12 Issue 2, p23 

    Cytoreductive nephrectomy as an independent option in patients with metastatic renal cell carcinoma (mRCC) cannot be considered as the only effective method, with rare exception, of a few patients with solitary metastases. Cytoreductive nephrectomy is now part of a multimodal approach...

  • Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).  // Current Medical Literature: Kidney Cancer;Dec2009, Vol. 1 Issue 4, p114 

    An abstract of the article "Nephrectomy Improves Survival in Patients with Invasion of Adjacent Viscera and Absence of Nodal Metastases (Stage T4N0 Renal Cell Carcinoma)," by U. Capitanio, P. Perrotte and L. Zini is presented.

  • Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand? Shahait, Mohammed; Mukherji, Deborah; El-Hout, Yaser // Indian Journal of Urology;Apr-Jun2015, Vol. 31 Issue 2, p102 

    Nephron-sparing surgery (NSS) for renal cell carcinoma (RCC) offers comparable oncologic results, but a lower risk of chronic kidney disease, when compared with radical nephrectomy. However, there are limited data in the literature examining the safety of NSS in the setting of metastatic RCC. To...

  • Percutaneous ablation of lymph node metastases using CT-guided high-dose-rate brachytherapy. COLLETTINI, F.; SCHIPPERS, A. C.; SCHNAPAUFF, D.; DENECKE, T.; HAMM, B.; RIESS, H.; WUST, P.; GEBAUER, B. // British Journal of Radiology;Jul2013, Vol. 86 Issue 1027, p1 

    Objective: To assess the technical feasibility, safety and clinical outcome of CT-guided high-dose-rate brachy- therapy (CT-HDRBT) for achieving local tumour control (LTC) in isolated lymph node metastases. Methods: From January 2008 to December 2011, 10 patients (six males and four females)...

  • Node burden key predictor in RCC without metastases. Allen, Penny // Urology Times;11/1/2004, Vol. 32 Issue 16, p13 

    Discusses a research showing that node burden is key predictor in renal cell carcinoma (RCC) without metastases. Nodal status of patients who had undergone radical nephrectomy and retroperitoneal lymph node dissection; Adjuvant therapy for RCC patients with node-positive disease and no...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics